Abrdn PLC Codexis, Inc. Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Codexis, Inc. stock. As of the latest transaction made, Abrdn PLC holds 4,200,950 shares of CDXS stock, worth $13.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,200,950
Previous 606,294
592.89%
Holding current value
$13.6 Million
Previous $1.63 Million
528.83%
% of portfolio
0.02%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CDXS
# of Institutions
139Shares Held
66.9MCall Options Held
37.7KPut Options Held
25.9K-
Opaleye Management Inc. Boston, MA9.5MShares$30.8 Million7.03% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$26.2 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$15.3 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$9.72 Million1.17% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $212M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...